Phase II, double blind, randomised, controlled study to evaluate immunogenicity, reactogenicity and safety of GlaxoSmithKline Biologicals Hib-menAC vaccine (Ghana)

Update Il y a 4 ans
Reference: ISRCTN35754083

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Not provided at time of registration


Inclusion criteria

  • Vaccination against meningococcal disease

Links